Alert Added Successfully

Endocrinology


               
Article Title Year Authour(s) Journal Subject Expert Rating Evidence Ranking
1. Short-term Administration of Supraphysiological Recombinant Human Growth Hormone (GH) Does Not Increase Maximum Endurance Exercise Capacity in Healthy, Active Young Men and Women With Normal GH-Insulin-Like Growth Factor I Axes 2005 Berggren, A., Ehrnborg, C., Rosén, T. J Clin Endocrinol Metab Endocrinology A
2. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence 2009 Arnold, J...R..., Arnold, D...F..., Marland, A... Clin Endocrinol (Oxf) Endocrinology B
3. Growth Hormone Deficiency after Treatment of Acromegaly: A Randomized, Placebo-Controlled Study of Growth Hormone Replacement 2010 Miller, K...K..., Wexler, T..., Fazeli, P... J Clin Endocrinol Metab Endocrinology A
4. Colonoscopic Screening and Follow-up in Patients With Acromegaly: A Multicenter Study in Italy 2005 Terzolo, M., Reimondo, G., Gasperi, M. J Clin Endocrinol Metab Endocrinology B
5. Short-Term Effects of Growth Hormone on Sleep Abnormalities in Prader-Willi Syndrome 2006 Miller, J., Silverstein, J., Shuster, J. J Clin Endocrinol Metab Endocrinology B
6. Continued Growth Hormone (GH) Treatment After Final Height Is Necessary to Complete Somatic Development in Childhood-Onset GH-Deficient Patients 2004 Attanasio, F., for the Hypopituitary Developmental Outcome Study Group. J Clin Endocrinol Metab Endocrinology A
7. Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study 2009 Colao, A..., Auriemma, R...S..., Galdiero, M... J Clin Endocrinol Metab Endocrinology A
8. PROP1 Mutations Cause Progressive Deterioration of Anterior Pituitary Function Including Adrenal Insufficiency: A Longitudinal Analysis 2004 Böttner, A., Keller, E., Kratzsch, J. J Clin Endocrinol Metab Endocrinology B
9. Conventional Pituitary Irradiation Is Effective in Lowering Serum Growth Hormone and Insulin-Like Growth Factor-I in Patients with Acromegaly 2006 Jenkins, P.J. J Clin Endocrinol Metab Endocrinology B
10. Gross Total Resection or Debulking of Pituitary Adenomas Improves Hormonal Control of Acromegaly by Somatostatin Analogs 2005 Petrossians, P., Borges-Martins, L., Espinoza, C. Eur J Endocrinol Endocrinology B
11. Risk for severe hypoglycaemia with unawareness in GH-deficient patients during the insulin tolerance test 2006 Holmer, H., Link, K., Erfurth, E.M. Clin Endocrinol (Oxf) Endocrinology B
12. Adult Growth Hormone Replacement Therapy and Neuroimaging Surveillance in Brain Tumour Survivors 2005 Jostel, A., Mukherjee, A., Hulse, P.A. Clin Endocrinol (Oxf) Endocrinology B
13. Changing Patterns of the Adult Growth Hormone Deficiency Diagnosis Documented in a Decade-Long Global Surveillance Database 2009 Webb, S...M..., Strasburger, C...J..., Mo, D... J Clin Endocrinol Metab Endocrinology B
14. Partial Surgical Removal of Growth Hormone-Secreting Pituitary Tumors Enhances the Response to Somatostatin Analogs in Acromegaly 2006 Colao, A., Attanasio, R., Pivonello, R. J Clin Endocrinol Metab Endocrinology B
15. The Natural History of Partial Growth Hormone Deficiency in Adults: A Prospective Study on the Cardiovascular Risk and Atherosclerosis 2006 Colao, A., Di Somma, C., Spiezia, S. J Clin Endocrinol Metab Endocrinology B
16. Baseline Characteristics and Response to 2 Years of Growth Hormone (GH) Replacement of Hypopituitary Patients With GH Deficiency Due to Adult-Onset Craniopharyngioma in Comparison With Patients With Non-functioning Pituitary Adenoma: Data from KIMS (Pfizer International Metabolic Database) 2005 Verhelst, J., Kendall-Taylor, P., Erfurth, E.M. J Clin Endocrinol Metab Endocrinology B
17. Outcome of Gamma Knife Radiosurgery in 82 Patients With Acromegaly: Correlation With Initial Hypersecretion 2005 Castinetti, F., Taieb, D., Kuhn, J.M. J Clin Endocrinol Metab Endocrinology B
18. Homozygous and Heterozygous Expression of a Novel Insulin-Like Growth Factor-I Mutation 2005 Walenkamp, M.J.E., Karperien, M., Pereira, A.M. J Clin Endocrinol Metab Endocrinology B
19. Significant tumour shrinkage after 12 months of lanreotide Autogel-120mg treatment given first-line in acromegaly 2009 Colao, A..., Auriemma, R...S..., Rebora, A... Clin Endocrinol Endocrinology B
20. Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to Pegvisomant 2005 Barkan, A.L., Burman, P., Clemmons, D.R. J Clin Endocrinol Metab Endocrinology B
21. Growth Hormone Releasing Peptide-2 (GHRP-2), Like Ghrelin, Increases Food Intake in Healthy Men 2005 Laferrère, B., Abraham, C., Russell, C.D. J Clin Endocrinol Metab Endocrinology B
22. The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly 2006 Dimaraki, E.V., Chandler, W.F., Brown, M.B. J Clin Endocrinol Metab Endocrinology B
23. Combined Therapy With Somatostatin Analogues and Weekly Pegviso-mant in Active Acromegaly 2005 Feenstra, J., de Herder, W.W., ten Have, S.M.T.H. Lancet Endocrinology B
24. Effects of an Oral Growth Hormone Secretagogue in Older Adults 2009 White, H...K..., Petrie, C...D..., Landschulz, W... J Clin Endocrinol Metab Endocrinology A
25. Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status 2006 Espinosa-de-los-Monteros, A.L., Sosa, E., Cheng, S. Clin Endocrinol (Oxf) Endocrinology B
26. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature 2006 Pantel, J., Legendre, M., Cabrol, S. J Clin Invest Endocrinology E
27. A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly 2009 Trainer, P...J..., Ezzat, S..., D'Souza, G...A... Clin Endocrinol Endocrinology A
28. A Reappraisal of Diagnosing GH Deficiency in Adults: Role of Gender, Age, Waist Circumference, and Body Mass Index 2009 Colao, A..., Di Somma, C..., Savastano, S... J Clin Endocrinol Metab Endocrinology B
29. The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly 2009 Karavitaki, N..., Fernandez, A..., Fazal-Sanderson, V... Clin Endocrinol Endocrinology B
30. Tumor Volume of Growth Hormone-Secreting Pituitary Adenomas during Treatment with Pegvisomant: A Prospective Multicenter Study 2010 Buhk, J...-.H..., Jung, S..., Psychogios, M...N... J Clin Endocrinol Metab Endocrinology B
31. Insulin-Like Growth Factor-I Response to a Single Bolus of Growth Hormone Is Increased in Obesity 2005 Walenkamp, M.J.E., Karperien, M., Pereira, A.M. J Clin Endocrinol Metab Endocrinology B
32. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed 2010 Reid, T...J..., Post, K...D..., Bruce, J...N... Clin Endocrinol Endocrinology B
33. Growth Hormone Treatment on Atherosclerosis: Results of a 5-Year Open, Prospective, Controlled Study in Male Patients with Severe Growth Hormone Deficiency 2008 Colao, A..., Di Somma, C..., Spiezia, S... J Clin Endocrinol Metab Endocrinology B
34. Clinically Silent Somatotropinomas May Be Biochemically Active 2005 Sakharova, A.A., Dimaraki, E.V., Chandler, W.F. J Clin Endocrinol Metab Endocrinology B